Metraipolis › archive › dc_ff26092ec2f0

Unlocking the potential of engineered circular RNA therapeutics — Europe PMC PMID:42004562

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42004562
DOI
10.1007/s44258-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-04T05:22:39.201Z
SHA-256 of the archived text
2b3af4a3e3684c4566b1ee7bf40fa07603490a0e6fdbdd7a45eec33ef8df8386
Stable URL of this page
https://metraipolis.com/documento/dc_ff26092ec2f0

How to cite

Unlocking the potential of engineered circular RNA therapeutics — Europe PMC PMID:42004562 — Europe PMC (en), https://europepmc.org/article/MED/42004562 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff26092ec2f0 (Metraipolis archive dc_ff26092ec2f0, sha256 2b3af4a3e3684c4566b1ee7bf40fa07603490a0e6fdbdd7a45eec33ef8df8386)
BibTeX
@misc{dcff26092ec2f0,
  title = {Unlocking the potential of engineered circular RNA therapeutics — Europe PMC PMID:42004562},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42004562},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff26092ec2f0; sha256 2b3af4a3e3684c4566b1ee7bf40fa07603490a0e6fdbdd7a45eec33ef8df8386},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42004562. Agents can read the archived copy with the MCP tool read_document.